Livzon Pharmaceutical Group Inc. (SHE:000513)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Chemical Drug Preparations	6.12B
Chemical Drug Preparations Growth	-6.87%
Active Pharmaceutical Ingredients and Intermediates	3.25B
Active Pharmaceutical Ingredients and Intermediates Growth	0.06%
Traditional Chinese Medicine Preparations	1.41B
Traditional Chinese Medicine Preparations Growth	-19.27%
Diagnostic Reagents and Equipment	718.43M
Diagnostic Reagents and Equipment Growth	9.02%
Biological Products	170.89M
Biological Products Growth	102.42%
Other Activities	52.01M
Other Activities Growth	5.18%
Sales Materials, Processing Charge, Etc.	51.39M
Sales Materials, Processing Charge, Etc. Growth	11.84%
Lease	8.33M
Lease Growth	-7.97%
Other	28.52M
Other Growth	108.69%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
China	9.98B
China Growth	-7.23%
Overseas	1.72B
Overseas Growth	9.69%